TUDOR INVESTMENT CORP ET AL - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 186 filers reported holding RELAY THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$431,298
-20.6%
66,150
+1.1%
0.00%
-33.3%
Q1 2024$543,160
+57.5%
65,441
+109.0%
0.00%0.0%
Q4 2023$344,767
-26.8%
31,314
-44.1%
0.00%
-40.0%
Q3 2023$470,901
-53.6%
55,993
+65.1%
0.01%
-79.2%
Q1 2022$1,015,000
-43.6%
33,922
-21.6%
0.02%
-52.9%
Q4 2020$1,799,000
+118.3%
43,286
+123.7%
0.05%
+41.7%
Q3 2020$824,00019,3470.04%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Grace Capital 183,112$5,665,0003.48%
Casdin Capital, LLC 3,668,574$115,670,0002.88%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$879,843,0002.73%
BVF INC/IL 2,049,113$64,609,0002.52%
Fernwood Investment Management, LLC 185,063$5,835,0002.00%
EcoR1 Capital, LLC 1,385,276$43,678,0001.52%
Boxer Capital, LLC 1,294,132$40,804,0001.42%
Integral Health Asset Management, LLC 140,000$4,414,0001.27%
Alphabet Inc. 1,641,497$51,756,0001.23%
Bellevue Group AG 3,755,962$118,426,0001.20%
View complete list of RELAY THERAPEUTICS INC shareholders